Vargas VE, Esquivel MMÁ, Obando VA, Quiroga GM

Language: Spanish
References: 13
Page: 1-7
PDF size: 809.45 Kb.

ABSTRACT

In the last years there has been a change in the surgery treatment of the sellar and parasellar pathology with the transnasaltransphenoidal endoscopic approach being actually the mainroute for the treatment of most of these lesions. In the Hospital Mexico, there is an endoscopic cranial base surgery unit since 2009 which from a multidisciplinary approach evaluates and treats these patients. In this article, a cohort of the patients with a transphenoidal approach for treatment of hypophysis adenomas in the 2012- 2013 years have been revised with a total of 47 patients. The mean age was 49 years, with more prevalence in women (62%). Most of the tumors were diagnosed as non-functional, followed by GH producers and ACTH producers. Aproximately half of the patients had a campimetry deficit and 17% had a previous surgery, most of them transcranial. 74% of the patients had macroadenomas, 13% microadenomas and 13% giant adenomas. The mean duration of the procedure was 247 minutes. The postoperatory cerebrospinal fluid leakage percentage was 1,5%. Suprarrenal insufficiency and insipid diabetes in the postoperatory period was slightly over 10%, however most of the cases were present since the preoperatory setting and were transitory.

REFERENCES

1. Instituto Nacional de Estadística y Censos. Total de Defunciones por grupo de edades, según grandes grupos de causas de muerte y sexo. 2010. San José, Costa Rica

2. Ortiz-Plata A et al. Chapter 5: Pituitary adenomas – clinicopathological, immunohistochemical and ultrastructuralstudy en el libro Rahimi-Movaghar, V. Pituitary Adenomas. Editorial InTech. 2012

3. DeMonte F Gilbert M Mahajan A McCutcheon I. Tumors of theBrain and Spine. Editorial SpringerScience- Business. 2007: 191-220

4. Tabaee A et al. Endoscopic pituitary surgery: a systematic review and metaanalysis. J Neurosurg 111: 545-554, 2009

5. Jagannathan J et al. Benign Brain Tumors: Sellar/Parasellar Tumors. NeurolClin 25 (2007) 1231-1249

6. Rojas D Palma A Wohllk N. Manejo de los adenomas hipofisiarios. RevChil- Neuro-Psiquiat 2008; 46 (2): 140-147

7. Chandler W Barkan A. Treatment of Pituitary Tumors: a Surgical Perspective. EndocrinolMetabClin N Am 37 (2008) 51-66

8. Cappabianca P et al. Endoscopic endonasal transsphenoidal surgery in recurrent and residual pituitary adenomas: technical note.MinimInvasiveNeurosurg. 2000 Mar; 43(1):38-43

9. Rudnik A et al. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas— firstexperience. MinimInvasiveNeurosurg. 2006 Feb; 49(1):10-4

10. Dehdashti A. Endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 2008; 62:1006- 1017

11. Cavallo L et al. Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series. WorldNeurosurg. 2013; 80 (3): 342-350

12. Dharambir S; Jern-Lin L. Endoscopic Pituitary Surgery. OtolaryngolClin N Am 39 (2006) 563-583

13. Senior B et al. Minimally Invasive Pituitary Surgery. Laryngoscope, 118 (2008): 1842-1855